| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Komasinski Michael | CEO, Director | C/O CRITEO LEGAL DEPT., 387 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK | /s/ Ryan Damon, as attorney-in-fact for Michael Komasinski | 23 Dec 2025 | 0002056554 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRTO | Ordinary Shares | Award | $0 | +125K | +242.08% | $0.00 | 177K | 22 Dec 2025 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. |
| F2 | The shares are subject to time-based vesting as follows: 2/3rd of the shares will vest on the two-year anniversary of the grant date, and the remaining 1/3rd will vest on the three-year anniversary of the grant date. Notwithstanding the foregoing, if the conversion of the Company into a Luxembourg company is completed before the first anniversary of the grant date, then 1/3rd of the shares will vest on the anniversary of the grant date, 1/3rd of the shares will vest on the two-year anniversary of the grant date and the remaining 1/3rd will vest on the three-year anniversary of the grant date. |
| F3 | For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). |